Adaptive Biotechnologies President Disposes Nearly $1 Million in Stock; Exercises Options as Company Posts Strong Q4 Results
Julie Rubinstein, president and chief operating officer of Adaptive Biotechnologies Corp (ADPT), sold 68,261 shares of common stock between April 6 and April 8, 2026 under a pre-arranged 10b5-1 trading plan, generating approximately $990,503 in proceeds. During the same period she exercised options to acquire 41,325 shares. The company also reporte…